<i>RIPK1</i> Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in MiceDenuja Karunakaran, Katey J. Rayner, Richard G. Jung et al.|Circulation|2020Cited by 233
RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in miceDenuja Karunakaran, Katey J. Rayner, Adam W. Turner et al.|Nature Metabolism|2020Cited by 59
Publisher Correction: RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in miceDenuja Karunakaran, Katey J. Rayner, Adam W. Turner et al.|Nature Metabolism|2020Cited by 1
Therapeutic inhibition of RIP1 improves metabolic dysfunction and inhibits atherosclerosis in mouse models of cardiometabolic diseasesDenuja Karunakaran, Katey J. Rayner, My Anh Nguyen et al.|The FASEB Journal|2018Cited by 1
Abstract 17409: Therapeutic Inhibition of RIP1 Improves Metabolic Dysfunction and Inhibits Atherosclerosis in Mouse Models of Cardiometabolic DiseasesDenuja Karunakaran, Katey J. Rayner, My Anh Nguyen et al.|Circulation|2017Cited by 0